Book contents
- Management of Complex Treatment-Resistant Psychotic Disorders
- Management of Complex Treatment-Resistant Psychotic Disorders
- Copyright page
- Contents
- Contributors
- Acknowledgements
- Abbreviations
- List of Icons
- Introduction
- Part I Treatment Strategies
- Part II Medication Reference Tables
- Appendices
- 3.01 Appendix Optimal Antipsychotic Plasma Concentration Ranges [–]
- 3.02 Appendix Optimal Mood Stabilizer Plasma Concentration Ranges [, ]
- 3.03 Appendix Formulas for Correcting QT Interval [, ]
- 3.04 Appendix Common Cytochrome P450 Inducers and Inhibitors [, ]
- 3.05 Appendix Management of Constipation [, ]
- 3.06 Appendix Child-Pugh Hepatic Function Scoring [, ]
- 3.07 Appendix Loading of Lithium and Valproic Acid [–]
- 3.08 Appendix Treatment of Prolactin Elevation [–]
- 3.09 Appendix A Select List of Foods High in Tyramine [–]
- 3.10 Appendix Medications That Present Risk for Serotonin Syndrome When Combined with Monoamine Oxidase Inhibitor [–]
- 3.11 Appendix Selected Treatment of Psychomotor Agitation Algorithm [–]
- Index
- References
3.01 Appendix - Optimal Antipsychotic Plasma Concentration Ranges [–]
from Appendices
Published online by Cambridge University Press: 19 October 2021
Book contents
- Management of Complex Treatment-Resistant Psychotic Disorders
- Management of Complex Treatment-Resistant Psychotic Disorders
- Copyright page
- Contents
- Contributors
- Acknowledgements
- Abbreviations
- List of Icons
- Introduction
- Part I Treatment Strategies
- Part II Medication Reference Tables
- Appendices
- 3.01 Appendix Optimal Antipsychotic Plasma Concentration Ranges [–]
- 3.02 Appendix Optimal Mood Stabilizer Plasma Concentration Ranges [, ]
- 3.03 Appendix Formulas for Correcting QT Interval [, ]
- 3.04 Appendix Common Cytochrome P450 Inducers and Inhibitors [, ]
- 3.05 Appendix Management of Constipation [, ]
- 3.06 Appendix Child-Pugh Hepatic Function Scoring [, ]
- 3.07 Appendix Loading of Lithium and Valproic Acid [–]
- 3.08 Appendix Treatment of Prolactin Elevation [–]
- 3.09 Appendix A Select List of Foods High in Tyramine [–]
- 3.10 Appendix Medications That Present Risk for Serotonin Syndrome When Combined with Monoamine Oxidase Inhibitor [–]
- 3.11 Appendix Selected Treatment of Psychomotor Agitation Algorithm [–]
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Publisher: Cambridge University PressPrint publication year: 2021
References
Meyer, J. M. (2014). A rational approach to employing high plasma levels of antipsychotics for violence associated with schizophrenia: case vignettes. CNS Spectr, 19, 432–438.CrossRefGoogle ScholarPubMed
Meyer, J. M., Cummings, M. A., Proctor, G., et al. (2016). Psychopharmacology of persistent violence and aggression. Psychiatr Clin North Am, 39, 541–556.CrossRefGoogle ScholarPubMed
Meyer, J. M. (2018). Pharmacotherapy of psychosis and mania. In Gilman: The Pharmacological Basis of Therapeutics (eds.). New York: McGraw-Hill.Google Scholar
Schoretsanitis, G., Kane, J. M., Correll, C. U., et al. (2020). Blood levels to optimize antipsychotic treatment in clinical practice: a joint consensus statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie. J Clin Psychiatry, 81(3), 19cs13169.Google Scholar